~~<i id='9D800B05A3'><strike id='9D800B05A3'><tt id='9D800B05A3'><pre id='9D800B05A3'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

Wikipedia

focus

author：Wikipedia 2025-08-12 08:27:26 - browse：6586

the shape of a medical note connected by dots and lines — health tech coverage from STAT — Adobe

In recent months, the federal government has repeatedly told Medicare Advantage insurers that they cannot use artificial intelligence or algorithms to deny medical services the government routinely covers.

But in finalizing a rule to that effect, it also stepped into a thicket of questions from insurers about a technology that is especially difficult to pin down: What is AI? Can it be used at all to make decisions about the coverage of older patients? If so, how?

This week, the federal agency that oversees Medicare sought to boil it all down into a simple directive: Put the circumstances of the individual patient first, and your algorithm second.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： As demand for Covid shots wanes, Moderna seeks its next success
Next article： Is there really a nursing shortage in the U.S.?

explore

knowledge

focus

Wikipedia

hotspot

SuzanneKreiterGlobestaffThestate’scelebratedclusterofbiotechshashatchedbreakthroughmedicinesforevery

WSS

Majority of Americans think Trump's Ga. election interference case is serious: POLL

As Maui death toll rises, number of missing remains unclear

Clinical trials must include more disabled people

Results on Novartis prostate cancer therapy could expand its use

Health tech investors get more selective as pandemic boom fades

ADCs take center stage as promising cancer treatments

Wikipedia

focus

explore

New air purifier tech could be key to improving indoor air quality

Hilary expected to bring catastrophic, life

Novavax promises a turnaround & Lilly roils the obesity market

Lung cancer is America's deadliest cancer. Yet so few get screened

Alkermes shareholders re

Smaller biotechs seek to piggyback on weight loss drug boom

Activists slam private health insurers over coverage restrictions

How AI can help patients find reliable information about doctors

How to save PrEP access — and even expand it

The future of Biogen: Pragmatism, ‘moonshots,’ and no Twinkies

knowledge

CZI to create biohub to build anti

Clinical trials must include more disabled people

Questions loom on AstraZeneca cancer drug as safety concerns ebb

Smaller biotechs seek to piggyback on weight loss drug boom

STAT Summit: Meghan O’Rourke on making chronic illness visible

How AI can help patients find reliable information about doctors

focus

Wikipedia

Wikipedia

hotspot